Wed, November 9, 2022

Bradley Canino Maintained (ZNTL) at Strong Buy with Decreased Target to $58 on, Nov 9th, 2022

Bradley Canino of Stifel, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Decreased Target from $70 to $58 on, Nov 9th, 2022.

Bradley has made no other calls on ZNTL in the last 4 months.



There are 4 other peers that have a rating on ZNTL. Out of the 4 peers that are also analyzing ZNTL, 0 agree with Bradley's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Bradley


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $60 on, Thursday, August 11th, 2022
  • Andrew Berens of "SVB Leerink" Maintained at Buy with Decreased Target to $42 on, Wednesday, August 10th, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $55 on, Wednesday, August 10th, 2022
  • Tyler Van Buren of "Cowen & Co." Initiated at Buy on, Tuesday, July 12th, 2022